Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2017

Year End Accounts and Preliminary Final Report

29 August 2017 by Justine Bednorz

Year End Accounts and Preliminary Final Report

Categories 2017, ASX Announcements

Appendix 4G and Corporate Governance Statement

29 August 2017 by Justine Bednorz

Appendix 4G and Corporate Governance Statement 2017

Categories 2017, ASX Announcements

BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited

28 July 201727 July 2017 by Audrey Thomson

BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited

Categories 2017, ASX Announcements

New Issue Announcement

19 July 2017 by Justine Bednorz

New Issue Announcement

Categories 2017, ASX Announcements

Appendix 4C

13 July 2017 by Audrey Thomson

Appendix 4C

Categories 2017, ASX Announcements

Appendix 3Y – Change of Director’s Interest Notice

5 July 2017 by Audrey Thomson

Appendix 3Y – Change of Director’s Interest Notice

Categories 2017, ASX Announcements

Appendix 3Y – Change of Director’s Interest Notice

28 June 2017 by Audrey Thomson

Appendix 3Y – Change of Director’s Interest Notice

Categories 2017, ASX Announcements

Appendix 3Y – Change of Director’s Interest Notice

28 June 201727 June 2017 by Audrey Thomson

Appendix 3Y – Change of Director’s Interest Notice

Categories 2017, ASX Announcements

New Issue Oversubscribed

23 June 2017 by Audrey Thomson

New Issue Oversubscribed

Categories 2017, ASX Announcements

Appendix 3Y – Change of Director’s Interest Notice

22 June 2017 by Audrey Thomson

Appendix 3Y – Change of Director’s Interest Notice

Categories 2017, ASX Announcements
Older posts
Newer posts
← Previous Page1 Page2 Page3 Page4 Next →
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 10 November 2025        Legal Notices and Privacy
Cleantalk Pixel